VTRO (Vitro Biopharma) Pretax Margin %: -208.32% (As of Oct. 2022)

What is Vitro Biopharma Pretax Margin %?

Vitro Biopharma VTRO Pretax Margin % is -208.32% as of Oct. 2022. The stock has 6 warning signs investors should review.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vitro Biopharma's Pre-Tax Income for the three months ended in Oct. 2022 was $-6.86 Mil. Vitro Biopharma's Revenue for the three months ended in Oct. 2022 was $3.29 Mil. Therefore, Vitro Biopharma's pretax margin for the quarter that ended in Oct. 2022 was -208.32%.

The historical rank and industry rank for Vitro Biopharma's Pretax Margin % or its related term are showing as below:

VTRO' s Pretax Margin % Range Over the Past 10 Years
Min: -4516.67 Med: -296.71 Max: -60.87
Current: -208.32

VTRO's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -90.5 vs VTRO: -208.32

Vitro Biopharma (AMEX:VTRO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Vitro Biopharma Pretax Margin % Related Terms

Vitro Biopharma Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Pretax Margin % Chart

Vitro Biopharma Annual Data

Trend

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Oct17

Oct21

Oct22

Pretax Margin %

Get a 7-Day Free Trial

-172.73

-248.48

-171.76

-344.93

-208.32

Vitro Biopharma Quarterly Data
	Oct00	Oct01	Oct02	Oct03	Oct04	Oct05	Oct06	Oct07	Oct08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15	Oct17	Oct21	Oct22
Pretax Margin %	Get a 7-Day Free Trial														-172.73	-248.48	-171.76	-344.93	-208.32

VTRO vs : Pretax Margin % Comparison

For the Biotechnology subindustry, Vitro Biopharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitro Biopharma Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vitro Biopharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Vitro Biopharma's Pretax Margin % falls into.

Save Embed

Vitro Biopharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Vitro Biopharma's Pretax Margin for the fiscal year that ended in Oct. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Oct. 2022 )	/	Revenue (A: Oct. 2022 )
	=	-6.86	/	3.293
	=	-208.32 %

Vitro Biopharma's Pretax Margin for the quarter that ended in Oct. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Oct. 2022 )	/	Revenue (Q: Oct. 2022 )
	=	-6.86	/	3.293
	=	-208.32 %

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of -208.32% mean?

Vitro Biopharma (VTRO) has a Pretax Margin % of -208.32% as of Oct. 2022. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vitro Biopharma and its competitors.

Is Vitro Biopharma's Pretax Margin % too high?

Vitro Biopharma's current Pretax Margin % is -208.32%.

How does Vitro Biopharma's Pretax Margin % compare to ?

Vitro Biopharma's Pretax Margin % of -208.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current Pretax Margin % is -208.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vitro Biopharma stock overvalued right now?

Vitro Biopharma (VTRO) has a current Pretax Margin % of -208.32%. The current Pretax Margin % is -208.32%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Pretax Margin % is -208.32% as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Industry Healthcare Biotechnology

Comparable Companies

Address 4621 Technology Drive, Golden, CO, USA, 80403

Website http://www.vitrobiopharma.com

Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.